Antinociceptive effect of dihydroetorphine in diabetic mice
- 4 February 1995
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 275 (1) , 109-113
- https://doi.org/10.1016/0014-2999(95)00013-b
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Evidence for differential modulation of μ-opioid receptor-mediated antinociceptive and antitussive activities by spleen-derived factor(s) from diabetic miceNeuropharmacology, 1994
- Effects of diabetes on the morphine-induced Straub tail reaction in miceNeuroscience Letters, 1994
- Streptozotocin-induced diabetes selectively reduces antinociception mediated by μ1-opioid receptors, but not that mediated by μ2-opioid receptorsNeuroscience Letters, 1994
- The role of the μ2-opioid receptor in the antitussive effect of morphine in μ1-opioid receptor-deficient CXBK miceEuropean Journal of Pharmacology, 1993
- Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic miceBrain Research, 1992
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992
- Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brainDiabetes, 1987
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- Irreversible opiate agonists and antagonists: the 14- hydroxydihydromorphinone azinesJournal of Neuroscience, 1982
- Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeineJournal of the American Chemical Society, 1967